Solution: Federal And State Policy

In The News ADVI Expert Discusses The Evolving Narrative Around Price-Gouging and Evidence-based, Market-Driven Tools as it Relates to PBMs with AIS Health
ADVI Instant

Insights,

| Brenna Raines, MHA - Vice President

ADVI Instant: CMS Releases the NBPP for 2024 Final Rule

Insights,

| Allison Schneider, MHA - Director

ADVI Analysis: MedPAC Meeting April 2023
ADVI Instant

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Senior Vice President, Market Access and Policy Strategy

ADVI Instant: CMS Releases the FY 2024 IPPS Proposed Rule

Evolving Healthcare Landscape: Cell and Gene
ADVI Instant

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Senior Vice President, Market Access and Policy Strategy

ADVI Instant: CMS Releases CY 2024 Changes to the MA and Part D Drug Programs Final Rule
ADVI Aware

Insights,

| Lindsay Bealor Greenleaf, JD, MBA - Senior Vice President, Market Access and Policy Strategy

ADVI Aware: Key Health Policy Topics in March 2023
ADVI Instant

Insights,

| Alicia Silver, MPP - Vice President, Emerging Therapies

ADVI Instant: OSTP Releases Report on US Biotech and Biomanufacturing Goals
ADVI Instant

Insights,

| Allison Schneider, MHA - Director

ADVI Instant: HHS & Commerce Dept. Announce Plan to Review March-in Authority